Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Microsoft buys into medical research software
- Microsoft is expanding its Health Solutions Group’s capabilities by acquiring assets owned by Merck division Rosetta Biosoftware. Rosetta’s software helps researchers analyse genetic and genomic study data. Microsoft says it wants to combine the software with its own Amalga Life Sciences platform. ...
- Articles 2009-06-02
- Online Ad Shop Rosetta Plus Brulant Equals New Dynamo in Digital
- Via ClickZ and MediaPost, breaking news today that Rosetta, a New Jersey-based indie digital firm is acquiring Brulant, a fellow traveler in the online waters based in Cleveland. The deal with make them one of the largest indepedent digital shops in the US, with a total of over 600 employees...
- Blog posts 2008-07-24
Additional Resources
- Genencor International Licenses the Rosetta Resolver Gene Expression Data Analysis System
- Business Editors & Health/Medical Writers BIOWIRE2K KIRKLAND, Wash.--BW HealthWire--March 11, 2002 Genencor International Licenses the Rosetta ResolverR Gene Expression Data Analysis System Rosetta Biosoftware today announced that Genencor International, Inc. (Nasdaq:GCOR) has licensed the Rosetta Resolver Gene Expression Data Analysis System. The Rosetta Resolver...
- Research articles 2002-03-11
- Agilent Technologies Increases Investment in Rosetta Biosoftware's Life Science Informatics
- PALO ALTO, Calif. & SEATTLE -- Agilent Technologies Inc. (NYSE:A) and Rosetta Biosoftware today announced that Agilent -- the exclusive distributor of the Rosetta Resolver and Rosetta Luminator gene-expression data analysis systems -- has increased its commitment to the continued development and enhancement of the Rosetta platforms. Agilent will provide...
- Research articles 2004-08-23
- Rosetta Resources Inc. to Delay Filing of Form 10-K and to Restate Previously Reported Third Quarter Net Income; Announcement of Material Control Weaknesses
- Rosetta Resources Inc. ("Rosetta"); (NASDAQ: ROSE) announced today that it will delay the filing of its annual report on Form 10-K for the year ended December 31, 2005, and that it will restate its financial statements for the third quarter of 2005. Rosetta previously filed an extension notice on...
- Research articles 2006-04-18
- Merck in Genomics Buy.(Merck and Company Inc. buys Rosetta Inpharmatics Inc.)
- Merck & Co., Inc. announced a definitive agreement to acquire genomics company Rosetta Inpharmatics, Inc. in a tax-free re-organization, valued at about $620 million. Each share of Rosetta stock will be converted into 0.2352 shares of Merck sto Merck & Co., Inc. announced a...
- Research articles 2001-05-14
- SPYRUS Chosen by National Security Agency to Provide Rosetta Smart Cards for the Defense Messaging System; NSA Purchases 20,000 ROSETTA Smart Cards for DMS Users
- WASHINGTON--BUSINESS WIRE--April 28, 1998-- SPYRUS today announced that the National Security Agency NSA has chosen SPYRUS' ROSETTA Smart Card for use as the basis for personal identification, authentication, and encryption within the Defense Messaging System DMS. Under the agreement, the NSA will...
- Research articles 1998-04-28
- Rosetta Biosoftware and Ingenuity Systems to Offer Interoperability between the Rosetta Resolver System and the Ingenuity Pathways Analysis System.
- SEATTLE & REDWOOD CITY, Calif., Jan 25, 2006 CCNMatthews via COMTEX -- Rosetta Biosoftware and Ingenuity Systems today announced a collaboration to establish interoperability between the Rosetta ResolverR system and the Ingenuity Pathways Analysis system. Researchers will be able to easily exchange data between the two...
- Research articles 2006-01-25
- Rosetta Biosoftware and Ingenuity Systems to Offer Interoperability between the Rosetta Resolver System and the Ingenuity Pathways Analysis System
- SEATTLE & REDWOOD CITY, Calif. -- Rosetta Biosoftware and Ingenuity Systems today announced a collaboration to establish interoperability between the Rosetta ResolverR system and the Ingenuity Pathways Analysis system. Researchers will be able to easily exchange data between the two systems to leverage both systems' ability to analyze gene expression...
- Research articles 2006-01-25
- Warnex and Rosetta Genomics Announce Exclusive Distribution Agreement for Rosetta's microRNA-Based Assays in Canada
- Warnex Medical Laboratories, a division of Warnex Inc. (TSX: WNX), and Rosetta Genomics, Ltd. (NASDQ: ROSG), the leading developer of microRNA-based molecular diagnostics, announced today they have signed an exclusive distribution agreement in Canada for three currently-available diagnostic tests. Under the terms of the agreement, Warnex will market...
- Research articles 2009-08-10
- FDA Licenses the Rosetta Resolver® System for Use in the Center for Drug Evaluation and Research
- SEATTLE -- Rosetta Biosoftware (NYSE:MRK) today announced that the U.S. Food and Drug Administration's Center for Drug Evaluation and Research CDER will evaluate the Rosetta Resolver system for gene expression data management and analysis. CDER will use the Rosetta Resolver system in the Voluntary Genomics Data Submissions VGDS program to...
- Research articles 2005-08-24
- Rosetta Resources Inc. Announces Post-Effective Amendment Declared Effective by SEC
- Rosetta Resources Inc. (NASDAQ: ROSE) announced today that its post-effective amendment to its registration statement on Form S-1 (333-128888) has been declared effective by the U.S. Securities and Exchange Commission. This post-effective amendment updates Rosetta's registration statement to include year-end 2005 and first quarter 2006 information about Rosetta.
- Research articles 2006-06-13
- Rosetta Biosoftware Integrates Affymetrix GeneChip Operating Software with the Rosetta Resolver System Version 5.0
- SEATTLE -- Rosetta Biosoftware today announced the integration of the Affymetrix GeneChipR Operating Software GCOS with version 5.0 of the Rosetta ResolverR gene expression data analysis system. The integration between the two systems will ease collaboration efforts between scientists, improve productivity in high-throughput gene expression laboratories, and seamlessly allow advanced...
- Research articles 2005-02-03
- MONSANTO Company and Rosetta Inpharmatics, Inc.(three-year collaboration in the area of crop discovery)(Brief Article)
- MONSANTO Company and Rosetta Inpharmatics, Inc. will convert their existing pilot agreement to a full-scale, three-year collaboration in the area of crop ... MONSANTO Company and Rosetta Inpharmatics, Inc. will convert their existing pilot agreement to a full-scale, three-year collaboration in the area...
- Research articles 2000-12-04
- Rosetta Biosoftware Licenses the Rosetta Resolver® Gene Expression Data Analysis System to the University of California, Los Angeles
- SEATTLE & LOS ANGELES -- Rosetta Biosoftware announced today that the University of California, Los Angeles UCLA licensed the Rosetta Resolver[R] system to support research at UCLA's Jonsson Comprehensive Cancer Center JCCC.
- Research articles 2007-02-26
- Rosetta Stone: IPO Market Continues Activity
- Tate Dwinnell submits: The IPO market continues to heat up with the Rosetta Stone RST IPO pricing at $18, above the expected range of $15 - 17, raising $112.5 million. The relatively small size of the float, combined with a lack of publicly traded competitors allowed the company...
- External links 2009-04-15
- Rosetta Biosoftware Licenses the Rosetta Resolver Gene Expression Analysis System to FoxHollow Technologies
- SEATTLE and REDWOOD CITY, Calif. -- Rosetta Biosoftware announced today that FoxHollow Technologies has licensed the Rosetta ResolverR system for research on cardiovascular disease. FoxHollow Technologies developed and markets the SilverHawkTM Plaque Excision System, an atherosclerotic plaque excision device approved in the U.S. for the treatment of peripheral arterial disease...
- Research articles 2006-03-13
- Oji Paper Co., Ltd. Licenses the Rosetta Resolver® Gene Expression Data Analysis System from Rosetta Biosoftware
- SEATTLE & TOKYO -- Rosetta Biosoftware announced today that Oji Paper Co., Ltd. in Tokyo, Japan licensed the Rosetta Resolver[R] system to characterize gene expression profiles of wood forming tissues. The Resolver system will be used in the Forestry Research Institute, which uses biotechnology applications to investigate which tree species...
- Research articles 2007-01-16
- Rosetta Biosoftware Licenses the Rosetta Resolver Gene Expression Analysis System to FoxHollow Technologies.
- SEATTLE and REDWOOD CITY, Calif., Mar 13, 2006 CCNMatthews via COMTEX -- Rosetta Biosoftware announced today that FoxHollow Technologies has licensed the Rosetta ResolverR system for research on cardiovascular disease. FoxHollow Technologies developed and markets the SilverHawkTM Plaque Excision System, an atherosclerotic plaque excision device...
- Research articles 2006-03-13
- Aker Kvaerner ASA wins umbilicals contract from Rosetta development offshore Egypt
- NORDIC BUSINESS REPORT-23 October 2006-Aker Kvaerner ASA wins umbilicals contract from Rosetta development offshore EgyptC1994-2006 M2 COMMUNICATIONS LTD http://www.m2.com The Norwegian engineering, construction and technology group Aker Kvaerner ASA said on Monday (23 October) that it has won a contract for five steel tube umbilicals for the Rosetta Phase...
- Research articles 2006-10-23
- << Previous
- page 1 of 1
- Next >>
Presented by American Express